Abstract
Sudden cardiac death represents a major problem in patients awaiting heart transplantation (HTx). A retrospective analysis of 1019 patients accepted for HTx revealed a high actuarial risk for sudden death accounting to 14% after 1 year and 20% after 2 years waiting time. Unterlying disease and hemodynamic characteristics had no predictive value. The use of implantable cardioverter/defibrillator therapy is discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Goldman S, Johnson G, Cohn J, et al, VHeFT Cooperative Study Group (1993) Circulation 87 (VI): 24–31
Defibrilat Study Group (1991) J Am Coll Cardiol 68: 545–546
Stevenson WD, Stevenson LD, Middlekauf HR, Saxon LA (1993) Circulation 88: 6 2953–2961
Packer M (1992) Circulation 85: 1 (I): 50–56
Loisance DY, Deleuze PH, Houei R, et al (1993) Ann Thorac Surg 55: 310–313
Jeevanandam V, Bielefeld M, Auteri J, et al (1992) Circulation 86 (II): 276–279
The Cardiac Arrhythmia Suppression Trial (CAST) Investigators (1991) N Engl J Med 324: 781–788
Metha D, Saksena S, Krol RB, et al (1993) PACE 16 (II): 179–185
Fieguth HG, Wahlers T, Trappe HJ, et al (1993) Cor Europ I: 2 75–77
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Fieguth, H.G., Wahlers, T., Trappe, H.J., Borst, H.G. (1996). Arrhythmogenic mortality in heart-transplant candidates. In: Mühlbacher, F., et al. Transplant International . Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-00818-8_55
Download citation
DOI: https://doi.org/10.1007/978-3-662-00818-8_55
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-61024-3
Online ISBN: 978-3-662-00818-8
eBook Packages: Springer Book Archive